3 ms·
This is my peers thesis. I may be doing this type or along this line. I think the problem is big data, in a non statistican sense, where you cannot get large a
by digitalzombie 10y ago
This is my peers thesis. I may be doing this type or along this line.
I think the problem is big data, in a non statistican sense, where you cannot get large amount of observation from patient. Either because of legal loop holes and/or the cost of getting enough patients for experiment and trials. This is for trials.
Even with phase III clinical trial it's less than 200 obs. This is not big data in the non statistician world. In our world big data mean tons of predictors. Medical data is usually high dimensional, less obs but tons of predictors, more columns than rows.
Also hospitals are wary of giving out data, either because of legal issues or because they know it's valuable so they don't want to share it. These two issue is compound it on the fact that the infrastructure is not there to share the data in one spot, it's fragmented across many other databases with different schema and what not.
But my peers and I have thesis involving cancer using genetic data. It's very promising, one of the recent thesis is about base on genetic data if the patient should take the surgery route or the chemo route and the model had a 80% accuracy rate and nice sensitivity rate (forgot what it was). The prediction is survival rate.
I also saw other comment about using genetic data against them. I think this is FUD because we have a law in place, GINA.